Growth Equity
Growth Credit
Healthcare
Contact
Menu
Investor Log in
Close
Growth Equity
Growth Credit
Healthcare
Contact
About Us
Team
Careers
Portfolio Roles
Insights
Portfolio
Investors
Home
/
Insights
/
Vaxxas recogniseds as 2013 BioSpectrum Asia-Pacific Emerging Company of the Year
Vaxxas recogniseds as 2013 BioSpectrum Asia-Pacific Emerging Company of the Year
17 March 2013
Posted in —
OneVentures
Share
Linkedin
Twitter
Copy Link
Read More
Share
Linkedin
Twitter
Copy Link
You may also like
10 June 2023
Healthcare
Biotech ImmVirX bucks VC desert to bank raise at $75m valuation
18 June 2023
Healthcare
Vaxxas opens world-class manufacturing facility to produce needle-free vaccine patch
06 December 2022
Healthcare
Needle-free vaccine innovator banks $34m
View All
Ventured. Gained.